B. Braun Medical SA
14
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
21.4%
3 terminated/withdrawn out of 14 trials
70.0%
-16.5% vs industry average
29%
4 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries
Role: lead
Performance and Safety of Lubri-cream for Pain Minimization During Urethral Catheterization and Cystoscopy
Role: lead
PMCF Study on the Safety of Linovera Emulsion for the Prevention of Cat-1 Pressure Ulcers, Vascular and DFU
Role: lead
PREMO Study: to Investigate Port REMoval Outcomes
Role: collaborator
Univation XM France
Role: collaborator
BE1 Study Spain - CAPSULE SYSTEM FOR COLOSTOMATES
Role: lead
Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients
Role: collaborator
Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation
Role: lead
Efficacy of Prontosan Solution on Chronic Ulcers
Role: collaborator
Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation
Role: collaborator
Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)
Role: lead
ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients
Role: lead
Effect of Prontosan Wound Irrigation Solution on Venous Ulcers
Role: collaborator
Functional Evaluation of Two Types of Totally Implanted Venous Ports
Role: collaborator
All 14 trials loaded